Intermediate-Density Lipoproteins
The Fork in the Road Between VLDL and LDL
In this chapter
Why This Matters
Intermediate-density lipoproteins (IDL) occupy a brief but important stage in lipoprotein metabolism. Although often overlooked, IDL represents the metabolic bridge between VLDL and LDL. The fate of these particles helps determine whether cholesterol is efficiently cleared by the liver or remains in the circulation as LDL. Understanding IDL is essential for appreciating how disturbances in lipoprotein metabolism contribute to atherosclerosis.
What Is IDL?
IDL is formed in the circulation as VLDL loses triglycerides through the action of lipoprotein lipase. As triglycerides are removed, the particle becomes smaller, denser, and relatively enriched in cholesterol, giving rise to IDL.
Unlike VLDL, which is primarily a triglyceride transport particle, IDL contains a higher proportion of cholesterol and represents a transitional stage in lipoprotein metabolism.
Each IDL particle contains one molecule of ApoB-100 and retains ApoE, allowing it to interact with hepatic receptors.
Two Possible Destinies
IDL has two possible metabolic pathways.
Approximately one-half of IDL particles are rapidly removed from the circulation by the liver through receptors that recognize ApoE. This efficient clearance prevents unnecessary accumulation of cholesterol-rich remnant particles.
The remaining particles undergo further triglyceride hydrolysis, primarily through hepatic lipase. As additional triglycerides are removed and ApoE is lost, IDL is converted into LDL.
This metabolic branch point is one of the most important transitions in lipid metabolism.
IDL as a Remnant Lipoprotein
IDL belongs to a group of particles collectively known as remnant lipoproteins.
Compared with their triglyceride-rich precursors, remnant particles are smaller, denser, and relatively enriched in cholesterol. Their size allows them to penetrate the arterial wall more readily than larger triglyceride-rich lipoproteins.
Once retained within the arterial intima, these cholesterol-rich remnants may contribute directly to the development of atherosclerosis.
Factors That Influence IDL Metabolism
The balance between hepatic clearance and conversion to LDL depends on several metabolic factors.
Normal hepatic receptor activity promotes rapid removal of IDL from the circulation. In contrast, impaired receptor function, increased VLDL production, insulin resistance, and defects in ApoE-mediated clearance may prolong the residence time of IDL and increase remnant particle concentrations.
These abnormalities contribute to both remnant hyperlipidemia and increased cardiovascular risk.
Clinical Relevance
Although IDL is not routinely measured in clinical practice, it plays an important role in cardiovascular disease.
Elevated concentrations of remnant lipoproteins have been associated with increased risk of atherosclerotic cardiovascular disease, even when LDL cholesterol levels are not markedly elevated. Patients with insulin resistance, type 2 diabetes mellitus, familial dysbetalipoproteinemia, chronic kidney disease, and mixed dyslipidemia often exhibit impaired remnant clearance.
Clinical Pearls
- IDL is formed from the metabolism of VLDL.
- Every IDL particle contains one ApoB-100 molecule.
- IDL either undergoes hepatic clearance or is converted into LDL.
- IDL is a cholesterol-rich remnant lipoprotein.
- Impaired remnant clearance contributes to atherosclerotic cardiovascular disease.
Common Misconceptions
Misconception: IDL is simply a temporary particle with little clinical importance.
Reality: IDL is a cholesterol-rich remnant lipoprotein that contributes to both LDL formation and atherosclerosis.
Misconception: All IDL particles become LDL.
Reality: Many IDL particles are removed directly by the liver before they can be converted into LDL.
Misconception: Only LDL contributes to cholesterol deposition within the arterial wall.
Reality: Cholesterol-rich remnant lipoproteins, including IDL, may also enter the arterial wall and contribute to plaque formation.
Clinical Bottom Line
IDL is the critical transition between VLDL and LDL. Whether these particles are efficiently cleared by the liver or remain in the circulation to become LDL has important implications for remnant accumulation, LDL formation, and cardiovascular risk.